Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular genetics of bladder cancer: an update.

Minerva urologica e nefrologica = The Italian journal of urology and nephrology - 1 Dec 2008

Díaz De Ståhl T, Segersten U, Malmström P U

Abstract excerpt

Urinary bladder cancer is a heterogeneous disease with tumors ranging from papillary non-invasive to solid muscle infiltrating high grade tumors. There are mainly three problems after initial management: recurrence, progression to higher stage and metastases. The respective risk is well known for each of the stages of the disease but not sufficiently for individual optimal risk assessments. The clinical need is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genes, ras
Share to In Situ Hybridization
Share to Karyotyping

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mitogen-Activated Protein Kinase Kinases

Share to Receptor, Fibroblast Growth Factor, Type 3

Share to Risk Assessment

Share to Tumor Suppressor Protein p53

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 18923358

Genes

FGFR3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular genetics of bladder cancer: an update.PMID 18923358Read ↗

Molecular genetics of bladder cancer: pathways of development and progression.Semantic proximity Read ↗

The evolution of bladder cancer genomics: What have we learned and how can we use it?Semantic proximity Read ↗

Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.Semantic proximity Read ↗

Molecular Basis of Urinary Bladder CancerSemantic proximity Read ↗

Molecular genetics and genomics progress in urothelial bladder cancerSemantic proximity Read ↗

Molecular pathogenesis of bladder cancer.Semantic proximity Read ↗

Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity.Semantic proximity Read ↗

[Recent advances in bladder urothelial carcinogenesis].Semantic proximity Read ↗

Molecular pathogenesis and diagnostics of bladder cancer.Semantic proximity Read ↗

Bladder cancer: molecular determinants of personalized therapy.Semantic proximity Read ↗

Bladder cancer subtypes defined by genomic alterations.Semantic proximity Read ↗

What we could do now: molecular pathology of bladder cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.